Page last updated: 2024-08-05 11:05:33

diamine

Any polyamine that contains two amino groups.

ChEBI ID: 23666

Members (17)

MemberDefinitionRole
1,2-diaminopropaneA diamine that is propane substituted by amino groups at positions 1 and 2. Propylenediamine is commonly used as a bidentate ligand in the formation of coordination complexes.propylenediamine
2-s-cysteinyldopaAn L-tyrosine derivative that is L-DOPA in which the hydrogen at position 2 on the phenyl ring is replaced by a cysteinyl group. Found in the urine of patients with melanoma.2-S-cysteinyl-DOPA
2,5-diaminotolueneA diamine in which the two amino groups are substituted into toluene at the 2- and 5-positions.2-methyl-1,4-phenylenediamine
2,6-diaminotolueneA diamine that is toluene in which both of the hydrogens ortho- to the methyl group are replaced by amino groups.2,6-diaminotoluene
5,6-diamino-2,4-dihydroxypyrimidineAn aminouracil in which the ring hydrogens at positions 5 and 6 on uracil have been replaced by amino groups.5,6-diaminouracil
amifostine anhydrousAn organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.amifostine
amn082A diamine that is ethane-1,2-diamine in which both amino groups are substituted by diphenylmethyl groups. It is an allosteric agonist of the metabotropic glutamate receptor 7 (mGluR7).N,N'-bis(diphenylmethyl)ethane-1,2-diamine
benzathinebenzathine
chir 99021A member of the class of aminopyrimidines that is 2-aminopyrimidine substituted at positions N2, 5 and 6 by (5-cyanopyridin-2-yl)ethyl, 4-methylimidazol-2-yl and 2,4-dichlorophenyl groups respectively.CHIR 99021
dimethyl-4-phenylenediamineN,N-dimethyl-1,4-phenylenediamine
ergolineAn indole alkaloid whose structural skeleton is found in many naturally occurring and synthetic ergolines which are known to bind to neurotransmitter receptors, such as dopamine, noradrenaline and serotonin receptors and function as unselective agonists or antagonists at these receptors.ergoline
jsh 23A diamine that is 1,2-phenylenediamine carrying a methyl substituent at position 4 and a 3-phenylpropyl substituent at position N1.JSH-23
pd 158780A pyridopyrimidine that is pyrido[3,4-d]pyrimidine-4,6-diamine in which the amino groups at positions 4 and 6 are substituted by a m-bromophenyl group and a methyl group, respectively. It is a potent, cell-permeable, reversible ATP-competitive inhibitor of EGFR tyrosine kinase activity [IC50 values of 0.008, 49 and 52 nM for EGFR, ErbB2 (HER2) and Erb4 (HER4)]. It does not inhibit FGF or PDGF-mediated tyrosine phosphorylation. Induces G1 cell cycle arrest in MCF10A cells and is antiproliferative in A431 human epidermal carcinoma cells.PD158780
pergolideA diamine that is ergoline in which the beta-hydrogen at position 8 is replaced by a (methylthio)methyl group and the hydrogen attached to the piperidine nitrogen (position 6) is replaced by a propyl group. A dopamine D2 receptor agonist which also has D1 and D2 agonist properties, it is used as the mesylate salt in the management of Parkinson's disease, although it was withdrawn from the U.S. and Canadian markets in 2007 due to an increased risk of cardiac valve dysfunction.pergolide
pramipexoleA member of the class of benzothiazoles that is 4,5,6,7-tetrahydro-1,3-benzothiazole in which the hydrogens at the 2 and 6-pro-S-positions are substituted by amino and propylamino groups, respectively.pramipexole
triethylenediamineAn organic heterobicylic compound that is piperazine with an ethane-1,2-diyl group forming a bridge between N1 and N4. It is typically used as a catalyst in polymerization reactions.triethylenediamine
wr 1065An alkanethiol that is the N-3-aminopropyl derivative of cysteamine. Used as the S-phosphorylated prodrug, amifostine, for cytoprotection in cancer chemotherapy and radiotherapy.WR-1065

Research

Studies (7,985)

TimeframeStudies, Drugs in This Class (%)All Drugs %
pre-19902,654 (33.24)18.7374
1990's1,743 (21.83)18.2507
2000's1,746 (21.87)29.6817
2010's1,536 (19.24)24.3611
2020's306 (3.83)2.80

Study Types

Publication TypeStudies, Drugs in This Class (%)All Drugs (%)
Trials981 (10.86%)5.53%
Reviews733 (8.11%)6.00%
Case Studies698 (7.73%)4.05%
Observational10 (0.11%)0.25%
Other6,613 (73.19%)84.16%